Keywords: japan, advisory, panel, review, sb, paxil, dossier
Japan advisory panel to review SB Paxil dossier
Article | 03 August 2000
On August 10, a Japanese Health Ministry advisory panel willconsider approval of: SmithKline Beecham's Paxil (paroxetine); Fujisawa's Myslee (zolpidem) for sleep ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
